Biomea Fusion, Inc.
General ticker "BMEA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $101.3M (TTM average)
Biomea Fusion, Inc. does not follow the US Stock Market performance with the rate: -1.3%.
Estimated limits based on current volatility of 5.9%: low 1.00$, high 1.13$
Factors to consider:
- Total employees count: 103 (+24.1%) as of 2023
- Top business risk factors: Product development risks, Operational and conduct risks, Regulatory and compliance, Third-party risks, Climate change and natural disasters
- Current price 61.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.10$, 9.12$]
- 2025-12-31 to 2026-12-31 estimated range: [2.65$, 7.70$]
Financial Metrics affecting the BMEA estimates:
- Positive: with PPE of -1.0 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -82.85 <= 0.33
- Positive: Investing cash flow per share per price, % of -0.25 > -0.66
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 64.52 > 63.39
Short-term BMEA quotes
Long-term BMEA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $83.63MM | $126.14MM | $144.07MM |
| Operating Income | $-83.63MM | $-126.14MM | $-144.07MM |
| Non-Operating Income | $1.81MM | $8.88MM | $5.64MM |
| R&D Expense | $62.71MM | $102.55MM | $118.08MM |
| Income(Loss) | $-81.83MM | $-117.25MM | $-138.43MM |
| Profit(Loss)* | $-81.83MM | $-117.25MM | $-138.43MM |
| Stockholders Equity | $108.54MM | $169.24MM | $51.57MM |
| Assets | $129.31MM | $199.93MM | $79.94MM |
| Operating Cash Flow | $-62.42MM | $-96.59MM | $-119.89MM |
| Capital expenditure | $1.03MM | $3.37MM | $0.36MM |
| Investing Cash Flow | $27.34MM | $-2.22MM | $-0.36MM |
| Financing Cash Flow | $1.24MM | $163.80MM | $1.67MM |
| Earnings Per Share** | $-2.80 | $-3.44 | $-3.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.